Brief: Microbot Medical® Shares Results From Its Pivotal Clinical Trial
09/04/2025 13:36
April 9 (Reuters) - Microbot Medical Inc MBOT.O: MICROBOT MEDICAL® SHARES RESULTS FROM ITS PIVOTAL CLINICAL TRIAL, ACHIEVING 100% ROBOTIC NAVIGATION SUCCESS FOR THE LIBERTY® ENDOVASCULAR ROBOTIC SYSTEM MICROBOT MEDICAL INC - LIBERTY(®) SHOWED A 92% REDUCTION IN RADIATION EXPOSURE WITH NO ADVERSE EVENTS REPORTED MICROBOT MEDICAL INC - SUCCESSFUL ROBOTIC NAVIGATION WAS ACHIEVED IN EVERY CASE AND MET PRIMARY ENDPOINT OF STUDY Source text: ID:nGNXbck9Lg Further company coverage: MBOT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones